Arkolith/Insider Trading/TLIS/Form 4

Blaser Brian J

President and CEO, DirectorTalis Biomedical Corp (TLIS) · full profile →Form 4 · filed Dec 2, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 1, 2021Grant(A)750K—$0750K
Dec 1, 2021Grant(A)625K—$0625K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-067642) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML